Fundraising Fox
/Companies
Sign in

AllRock Bio

Natick, US · 21 employees on LinkedIn · 3 known investors

Find your way into AllRock Bio

Sign up to see every warm intro you have to AllRock Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the AllRock Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

AllRock Bio is a drug development company advancing novel therapies for pulmonary hypertension, interstitial lung diseases, and other fibrotic conditions. Its lead program is an orally administered pan-ROCK inhibitor being investigated in pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease.

Biotech

Founders & leadership

CPCatherine Pearce
Catherine PearceCEO & FounderAdvisor at CincyTech
D
DHScFounder
JRJustin R Thompson
Justin R ThompsonCBO and founderFounder at Allrockbio

Investors · 3

Westlake BioPartners✓ confirmed by AllRock BioWestlake Village

How we know: the company's own site · Not right? Tell us

Westlake Village BioPartnerslisted by Westlake Village BioPartnersLos Angeles · $100K – $5M

How we know: Westlake Village BioPartners's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us

Founder mafia

2 people who came through AllRock Bio went on to found or lead other companies.

Catherine Pearce, DHScCEO & FounderFounded JucaBioJustin R ThompsonFounderFounded JucaBio

Related companies · 3

Scholar RockScholar Rock is a biopharmaceutical company that develops therapies targeting growth factor proteins to treat serious diseases. The company uses a selective protein targeting approach designed to inhibit disease mechanisms rather than manage their downstream effects.
Aro BiotherapeuticsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.
Korro BioKorro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology. It aims to create genetic medicines for patients with rare and highly prevalent debilitating or life-threatening diseases.

Companies working in the same space as AllRock Bio.

Frequently asked questions

What does AllRock Bio do?
AllRock Bio is a drug development company advancing novel therapies for pulmonary hypertension, interstitial lung diseases, and other fibrotic conditions. Its lead program is an orally administered pan-ROCK inhibitor being investigated in pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease.
Who founded AllRock Bio?
AllRock Bio was founded by Catherine Pearce, DHSc, Justin R Thompson.
Who are AllRock Bio's investors?
AllRock Bio's investors include Versant Ventures, Westlake BioPartners, Westlake Village BioPartners.
Where is AllRock Bio headquartered?
AllRock Bio is headquartered in Natick, US.